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10 trict rules can be laid down for the treatment of
snakebite, but frequent inquiries from colleagues and lay-
men indicate that some suggestions may be acceptable.
even if they are over-simplified and open to criticism.
All patients suffering snakebite hould be referred to a
hospital or doctor for observation and treatment if
necessary. The patient can be dismissed in cases of
known viper bite if no signs of poisoning have appeared
after a few hours. Patients bitten by an elapid snake
(cobra, ringhals, mamba) or an unidentified snake should
be observed for 24 hours. A patient suffering a suspected
or known boomslang bite should be kept under observa-
tion for 3 or 4 days.
Serum treatment should take place under medical super-
vision whenever this is possible, but the suggestions pre-
sented in Table I were formulated with the assumption
that the treatment before hospitalization would be carried
out by a lay person. In the rare case when the patient
himself, or one of his companions, is medically qualified
the cheme sbould be modified; e.g. intravenous rather
than intramuscular injections would be recommended.
RECOG ITlON OF A S AKEBITE
Signs and Symptoms of Snakebite Poisoning
The boomslang injects a haemotoxic poison causing
local pain, headache, nausea, omiting, abdominal dis-
comfort, bleeding from the mucosa and into the skin and
a coagulation defect.
Viper bite, which is cytotoxic, causes severe local pain,
welling and induration, cellulitis, haemorrhages (ecchy-
moses) and necrosis. There is gross extravasation resulting
in oligaemic shock, tbe cause of death in serious viper
(puffadder) bite.'
Elapid bites are neurotoxic with little or no local pain
or swelling. Dizziness, vomiting, restlessness, increased
salivation, sweating, difficult swallowing and speech,
ptosis, impaired eye movement, congested conjunctivae,
respiratory distress and terminal failure are the usual
igns and symptoms.
Identification of the Snake
It is always desirable to establish the identity of the
offending snake, and it should be brought for identification
if it has already been captured or killed. Identification may
be of vital importance in c.ountrie and areas where only
monospecific sera are available, but is less important in
South Africa where the boom lang and the mambas are
usually recognized and the other dangerous snakes are
covered by a single polyvalent serum. Special attempts to
capture or kill the snake should therefore not be made.
ince they would only result in more casualties.
Fang Marks
A person may claim to have been bitten when a snake
has struck at him ineffectively, in which case there will be
no puncture marks and he should receive no treatment
'Dale received: 30 July 1969.
but be calmed and kept under ob ervation; the fang mark
could be obscured by dirt or be invi ible in the hard callu
of a foot.'
An effective snakebite may re ult in a pair of clearly de-
fined puncture wounds but there may be additional mark,
in elapid bites sometimes caused by other teeth in the
snake's jaws. There will be only a ingle puncture mark if
only one fang has penetrated and in ome cases the site of
the bite shows only a scratch. Though highly variable, the
appearance of the fang marks may help in establishing the
type of offending snake and in estimating the likely severity
of the bite, but it should be remembered that despite ob-
vious puncture the snake may not have injected any venom,
and that no venom may have entered a superficial wound,
in which case no poisoning will result; on the other hand a
mere scratch caused by a boomslang can have serious con-
sequences.
A patient may present for urgent erum treatment with a
wound on a bare foot which could have been caused by a
snake; but no snake was seen and there was no immediate
pain. If, on arrival for consultation (usually after some de-
lay), there is no local change or sy temic involvement indi-
cating poisoning, such a patient should not be given serum
but should be kept under observation for a while; he was
probably injured by ome object lying in the grass.
TREATMENT
Incision
Incisions are still occasionally recommended as a first-aid
measure in certain types of snakebite, but most authorities,
including Reid' and Chapman,' con ider it a risky or useless
procedure which therefore should be omitted. Further-
more, it may delay other and more important form of
treatment and add needlessly to the uffering of the patient.
Suction
Experimental studies with rattle nake venom have de-
monstrated that substantial amounts of venom can be re-
moved by suction in combination with incisions if applied
early enough.'" Similar experiments have not been carried
out with African venoms but there is reason to believe that
some venom may be removed in this way: Applied to the
fang marks without incision, suction can do no harm and
give the patient the reassuring feeling that something is
being done. The use of the unguarded mouth may carry
a Light risk for the person ucking and be the cau e of
infection in the patient, and suction is therefore best carried
out with the mechanical device included in snakebite kit.
Suction should not, however, upersede or take priority
over other form of treatment.
Tourniquet
The lethal toxins in elapid venom are polypeptides with
little or no local action, but, being rapidly absorbed directly
into the blood tream," they may exert their neurotoxic
action soon after a bite. Con equently, the ubcutaneous
median lethal dose (LDso) of elapid venom for mice is only
from 10% to 20o~ larger than the intravenous LD",. The
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lethal potency of viper venoms is about 8 times less when
injected under the skin rather than into a vein, which is
not surprising because the large molecular viper toxins are
slowly absorbed via the Iymphatics: They cause devastating
local tissue destruction, and according to Chapman' death
due to viper bite is usuaUy due to oligaemic shock.
A tourniquet is therefore of problematic value and not
generally recommended in viper bite, whereas its value in
delaying systemic poisoning with elapid venoms was de-
monstrated by the late Dr E. Grasset' and has been con-
firmed in mouse experiments (see Appendix I).
The tourniquet should be arterial and placed on the
upper arm or high on the thigh, depending on which limb is
bitten. It should not be applied for more than It hours and
may be released for a few seconds every 30 minutes.' It
should be discarded altogether as soon as an adequate dose
of antivenom has been Injected intravenously, but should
be retained as long as possible without undue risk of per-
manent damage to the function of a limb when the serum
has been given by any other route, thus aUowing as much
serum as possible to be absorbed before the venom enters
the circulation.
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Sentl1l Treallnelll
The following sera are available for u e in outh frica:
1. PolYI'alellt amil'elloJll (Hiti, aja, Hemachatu ). This
erum i specific against the venom of the puffadder (Bilis
arietans), the Gaboon viper (Bitis gabollica), the Cape
cobra ( laja nivea) and the ringhals (Hemachatlls haema-
chalUs). It al 0 neutralize the venoms of the Egyptian
cobra ( . haje), the spitting black-necked cobra ( . nigri-
co//is), commonly called the m'fesi, the venom of the rare
black-lipped forest cobra . melanolellca), and tho e of
various non-African cobra. It has mea urable paraspecific
action on the venoms of our night adders (Callslls species)
and horned adder (genus Bitis), but it i disputable if
serum should be used in ca e of bite by the e les er viper
and their name have therefore been placed in brackets in
Table I. either this nor any other erum has any effect
on the venom of the berg adder (B. atropos) and serum
treatment in ca es of berg adder bite is therefore point-
less. Per ons bitten by this snake have shown signs of
neurotoxic poisoning (ophthalmoplegia) but have recovered
without sequelae. Though experimental evidence i lack-
ing, there is no reason to believe that any available serum
will neutralize the venom of the burrowing adder
(Atractaspis bibrom) and erum treatment i not ju ti-
fiable.
Due to the adoption, ome time ago, of additional im-
munization of the horses with mamba venom, recent
issue of this polyvalent serum have marked potency
against the venoms of the e nake, and may be used a
an emergency measure in cases of mamba bite although
their mamba antivenom titre i not as high a that of the
recommended specific mamba serum listed below.
2. Polyvalent antivenom (Dendroaspis). This serum i
specific again t the venoms of the green mamba (Dendro-
aspis angusticeps), the black mamba (D. polylepis) and
Jameson's mamba (D. jamesom), and has marked para-
specific action against the venom of the fourth African
mamba, D. viridis; only the first two mentioned mamba
are found in South Africa.
This serum may have some action on the venom of
certain other snakes but hould be reserved for use in
case of mamba bite.
3. Boomslang (Dispholidlls typus) antivenom. Thi
serum i not for general issue. A mall freeze-dried tock
i held at thi Institute for issue to hospitals and doctors
treating patients bitten by this particular snake. It cannot
be expected to have any effect on the venoms of other
nakes, back- or front-fanged. The low on et of erious
boom lang envenoming and the efficacy of the serum
even after a considerable delay in treatment make it
possible for upplie to reach any part of the country in
time if this Institute is notified at once.
The Route of Injection and Efficacy of Serum
The effect of erum in viper bite may not appear im-
pres ive when the result in ho pitalized patients are ur-
veyed'-possibly partly because mo t patients are admitted
late and any erum admini tered before admi sion i not
alway given oon enough, by the be t route, or in ade-
quate do age.
Laboratory ob ervation and limited clinical experience
leave one with no doubt that swift infiltration with erum
of the ite of venom introduction will either aboli h or
reduce the effect of viper venom. Local erum infiltration
may, of cour e, not only be ery painful but al 0 inad-
i able when ertain part of the body su h a. a digit are
bitten.
Whether or not ome erum i injected into or near the
ite of the bite, the bulk is usually injected el ewhere
under the kin or into a muscle and not by the route
through which it will reach its target with a minimum of
delay, i.e. intravenously.
Working with rattle nakes, Gennaro and McCollough'
have recorded that about 86°~ of labelled antivenom ad-
mini tered intravenously may accumulate at the ite of
the bite within 2 hours after admini tration. Experi-
ment in thi laboratory have shown that mall amounts
of antivenom injected into the blood stream of guinea-
pigs within 10 - 15 minute after the venom injection will
clearly reduce the ize and everity of the local le ion
caused by the injection of puffadder (Bilis arieTalls)
venom into their shaven skin.
There is no particular rea on to infiltrate the bitten ite
with antivenom in ca e of bite by elapid snake which
have no local effect, but a local injection might po ibly
be more effective than injection into other part, and the
patient may feel comforted becau e to him it is the ob-
vious ite to choose.
The efficacy of pecific erum gi en intravenou Iy to
patient with already e tablished y temic elapid poi oning,
often mentioned in the earlier literature, ha recently been
confirmed not only here,"" but aloin Asia' and Austra-
lia," and is supported by the results of laboratory experi-
ments (Appendix 2).
However, antivenoms are commonly injected under the
skin or into a muscle, not only by the layman who can-
not do otherwise, but al 0 by doctor. What i the value
of thi ?
For a given amount of serum the alue will depend on
the potency of the erum, on the rate of erum ab orption.
and on the amount of venom injected by the nake.
The potency of the era mentioned above i high, and
fairly constant from one batch to another. s far a the
erum absorption rate i concerned, it i po ible to deter-
mine the rate of increa e in the blood-antibody concentra-
tion in human beings after a ingle large ubcutaneou or
intramuscular do e of diphtheria or tetanus antitoxin,
which in their propertie are akin to antivenom. uch ex-
periment have bown that only about one-third of the
injected antitoxin will have entered the circulation after
12 hours and that the maximum concentration in the
blood will not be reached until 36 - 48 hour after the
injection."
irnilar in e tigation cannot be carried out with anti-
venom in human being, but experiment in mice (Ap-
pendix 3) have hown that only about 16% of the injected
anti venom had entered the circulation after 30 minutes.
about twice a much in an hour, and the maximum con-
centration of circulating antibody wa not reached until
about 15 hour after the erum had been injected ub-
cutaneously or intramuscularly.
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The amount of venom injected by a snake in a bite is un-
certain, but even if it is assumed that the average yield on
milking a full-grown ape cobra, about 120 mg.: indi-
cates the amount likely to be delivered in a naturally oc-
curring bite, and if one may reason from mouse to man.
one would expect (Appendix 2) that from 30 to 40 ml. of
antivenom (the contents of 3 - 4 ampoules) given intra-
venously would be life-saving for human beings even
after a considerable delay. But if, as in the mouse, about
30 times as much erum would have to be injected under
the kin or into muscle to have the same effect (Appendix
3) then one might as well not inject any serum at all.
This attitude is probably too cynical. Some serum would
be absorbed and could reduce the local damage caused
by viper venom or delay death from elapid venom
poisoning long enough for effective treatment to be insti-
tuted, as may have been the case in the mamba bite re-
ported by Krengel and Walton.'
The Intravenous Dose
It is impossible to suggest a 'standard' dose, but, con-
sidering clinical data, the amount of a venom likely to be
injected and its mode of action, and the potency of cur-
rently available antivenoms, the following doses are sug-
gested:
The contents of 2 - 4 ampoules (20 - 40 m!.) should be
given when bites by either the puffadder or the Gabo:m
adder necessitate intravenous therapy, which probably is
uperf]uous in ca es of bites by other vipers.
The contents of 3 or 4 ampoules (30 or 40 m!.) of the
appropriate serum are needed in elapid bite treated be-
fore or soon after signs of systemic poisoning are ap-
parent, followed by more serum if the response is unsatis-
factory. The dose in ad anced systemic poisoning should
be 2 or 3 times as large.
The few patients so far treated with specific boomslang
antivenom received the contents of I - 4 ampoules when
poisoning was well advanced, and all survived.
The Dangers of Antivenom Treatment
Although the antivenoms discussed here are pepsin-
refined globulins, delayed serum reaction (serum sickness)
must be expected in ome of the patients. It will occur in
about 8% of treated Whites, whereas the expectation of
serum sickness in pigmented patients is lower, which is
fortunate because they are the main sufferers of snakebite.
The patients should be warned about the possibility of
serum sickness when they are dismissed, so that they can
call for prompt treatment (antihistaminics, steroids) if
necessary. Serious acute serum reactions are rare, and
fatal reactions rarer still. In fact, the risk of fatal ana-
phylaxis must be considered minute compared with the
risk to life or limb when a full bite has been inflicted by
one of our dangerous snakes. Even so, antivenom should
not be injected lightly and the usual rules for serum
treatment hould be followed as far as possible.
Except in cases of emergency, antivenoms should not
be given in therapeutic dosage without a prior trial dose.
Lay persons may have to omit it, but in the case of a fatal
reaction a doctor might find himself in difficulties if, in
the opinion of others, the circumstances would have per-
mitted a cautious approach.
The trial dose is particularly important in patients with
known hypersensitivity to horse serum or with a history
of serious allergic manifestations (e.g. asthma or infantile
eczema). Such patients should not be given antivenom if
this is at all avoidable; if not, they should be tested
subcutaneously with 0·1 or 0·2 ml. of serum diluted 1 : 10
or even I : lOO in sterile saline or water. Other patients
may be tested with a similar volume of serum diluted
I : 10, or even undiluted serum if a suitable diluent is
not available. The patient should be under constant obser-
vation for at least 30 minutes and, needless to say, adre-
naline should be at hand, already drawn into a syringe.
Antihistaminics and steroids, and possibly coramine, may
also be of value in the treatment of anaphylaxis. In the
absence of signs of hypersensitivity, the full therapeutic
dose can be given, but the patient must remain under
constant observation.
The attending physician is left with a very difficult de-
cision if the trial dose triggers off an anaphylactic shock.
If in his opinion serum treatment is essential in order to
save the patient's life, he can but wait for the patient to
recover-in particular, for his blood pressure to return to
a normal or reasonable value-then give another trial
dose, observe again, and proceed as carefully as possible.
Luckily for the doctors, most patients have already re-
ceived some serum without ill-effect before they arrive,
which makes it possible to proceed without trial doses;
this is not always realized.
It should be mentioned that a patient seen in a state
of collapse after a snakebite may not be suffering from
venom poisoning but may have reacted to injected serum,
and he should be treated accordingly. Attention should
also be called to the observation made by Reid,'
that a state of semiconsciousness with cold clammy
skin and rapid shallow breathing may be the result of
fright, and is most effectively treated with a placebo
injection.
General Management
The usual recommendation is to keep the patient warm,
but if one can judge from the results of mouse experi-
ments (Appendix 4) it might be better to keep him com-
fortably cool.
1£ possible, the patient, or at least the affected limb,
should be immobilized. A pressure dressing applied with
care in a known puffadder bite and before the swelling
has progressed is recommended by Chapman,' who also
suggests that a neutral position, rather than elevation or
lowering of the affected limb, is preferable.
Antihistaminics and steroids have a place in the treat-
ment of serum reactions but have no proved effect on
local or systemic snakebite poisoning. They are sometimes
contraindicated, and steroids particularly should be used
with caution if they are used at all. It is too early to
form any opinion on the possible clinical value of pro-
teinase inhibitors and chelating agents.
For fear of respiratory depression the use of morphine
to overcome pain is not considered desirable in snakebite.
This seems reasonable in elapid poisoning, which in any
case is not particularly painful, but less so in cases of
viper bite. It may, however, be safer to rely on aspirin
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*The venom was injected sulx:utaneous)y. the serum a indicated. in mice.
TABLE 11. THE EO", (pI.) AND ITS 5% FIDUCIAL LIMITS FOR A
SERUM TESTED WITH 50 pg. OF N. nivea VENOM·
necessary dose increased teeply with further delay and, though
ome mice could still be aved, there was no ignilicant rc-
gression of survival rate on erum dose after 40 min. and there-
fore eemingly no (Xlint in giving partiCUlarly large doses; omc
mice were obviously beyond saving even if the serum delayed
death. Artificial respiration, not easily applied to mice, would
probably save some human beings in the same situation. Mice
challenged with 50 pg. of venom, the dose used in the experi-
ment, but given no serum survived for 69 min. on the average:
the probability of survival for less than 40 min. or more than
115 min. was le s than 0·01.
5°~ limits
11·7 - 10·-














3. The Rate of Alltivenom Absorption after a Subcutaneo/ls or
ItUram/lsc/llar lnjection
The relationship between the intravenous dose of N. lIivell
venom and the time to death of mice is known," and 50 Ilg.
of the venom preparation used here would kill mice in a mean
log. time corresponding to just under 9 min. The potency of
the serum used in these experiments was such that 16 Ill. would
just render 50 Ilg. of venom harmless when these amounts of
the two reagents were mixed and injected under the skin (the
calculated ED.. of the serum). All the mice in a large group
were given this amount (16 pI.) of serum under the dorsal skin
and challenged in groups of 10 with 50 Ilg. of venom intra-
venously after t, 1,2,4,8, 16, 32,64 and 128 hours. The time
to death was recorded for each mouse and from the known
relationship between death-time and dose an estimate was ob-
tained of the amount of venom left unneutralized at the differ-
ent challenge times and therefore free to exert its lethal effect.
The difference between this estimate and 50 p..g., the do e
injected, indicated the proportion of serum absorbed from the
subcutis.
The resulting absorption curve conformed closely with the
theoretically determined blood concentration-time relationship
discussed in general by HeintzU for substances injected in this
way. Increasing at a steady rate relative to the logarithm of
time, the concentration of circulating antivenom reached a
ma.ximum after about 15 hours and only about one-third of the
injected serum had entered the circulation after one hour.
The results obtained when the intramuscular route was used
were essentially the same and did not, as one might have
expected, indicate that this route of injection was superior.
The absorption curve indicated that about 16°~ of the
serum injected subcutaneously (or intramuscularly) reached the
circulation in about 30 min. Reference to Table II will show
that this amount would have to represent about 15 pI. if half
the mice were to be saved. One might thus expect that about
90 pI. of serum injected subcutaneously without delay would
have this effect, but direct experiments showed that considerably
more serum was required. The ED", of the same serum injected
subcutaneously on one side of mice which immediately be-
fore had received 50 p..g. of venom under the skin of the other
side was found to be about 500 pI. with wide 5°~ fiducial
limits (790 - 258).
The reason for this is not clear, but very large do e are
obviously required when the serum is injected ubcutaneou Iy
or intramuscularly even at once, and any delay would make it
almost or completely ineffective.
Semm administration
Serum mixed with venom
Serum intravenously immediately
Serum intravenou ly after 10 minute
Serum intravenously after 20 minutes
Serum intravenously after 30 minutes
Serum intravenously after 35 minutes
Serum intravenously after 40 minutes
APPEl\'OIX
I. The Tourniquet
An occlusive tourniquet in the form of a 3-mm. wide elastic
band was placed above the left knee of 10 mice and a dose con-
ta.ining 100 Ilg. of N. nivea venom in 0·1 ml. saline solution
was injected into the muscle below the tourniquet. Ten other
mice served as controls and received the same venom dose but
no tourniquet was applied. The controls died in from 43 to 77
min., the mean log. death time being 1·749, corresponding to
56 min. One mouse in the tourniquet group died after 74 min.
and another showed serious poisoning after 80 min. (the
tourniquets presumably being faultily applied) when the other
8 mice appeared normal. There was clearly no need to pro-
long the animals' discomfort. The tourniquets were removed
and the surviving 9 mice were given 30 Ill. of serum intra-
venously, which protected all but the seriously envenomed
mouse which died after 6 hours.
The serum-saving value of a tourniquet was demonstrated by
determining the subcutaneous ED", of serum injected im-
mediately after an intramuscular challenge with 50 Ilg. of N.
lIivea venom in mice without a tourniquet and in mice with a
tourniquet left in place for 30 minutes. The ED50 and 5°0
probability limits were 349 Ill. (633 - 191) and 129 Ill. (177 - 92)
for the two groups respectively.
The tourniquet caused marked oedema and paresis of the leg.
but normal appearance and function were completely re-
stored in 1 - 2 weeks.
2. The Efficacy of llltraveno:ls lnjeceion
To demonstrate the efficacy of intravenous serum treat-
ment in poisoning with elapid venom, a dose of 50 pg. (about
5 median lethal doses) of N. nivea venom contained in a
volume of 0·25 ml. was injected under the dorsal skin of mice
weighing from 16 to 18 G and the intravenous ED50 of a
specific serum was determined by the injection of graded doses
immediately afterwards, and after 10, 20, 30, 35 and 40 min.
The results, evaluated by the probit method, are shown in
Table II, which also shows the ED", of the serum injected sub-
cutaneously mixed with the venom.
Injected at once intravenously, the amount of serum required
to neutralize the venom is only slightly larger than the
amount required if the serum and venom are injected as a
mixture under the skin, and a very moderately increased dose
will save the mice even when 30 min. are allowed to lapse. The
and give the patient a little alcohol, if be requests it and
it helps him to relax. At one time held to be an antidote,
alcohol is today usually prohibited in snakebite-though
not by all autborities'-and the results of mouse experi-
ments (Appendix 5) do not indicate any dangerous effect.
Suitable antibiotics may be used to prevent or treat in-
fection, and the patienfs immune state with regard to
tetanus should be ascertained.
There is no reason to think that the uncomplicated
bite by a snake is a particularly 'tetanus prone' wound,
and tetanus antitoxin should therefore be used with dis-
cretion, but non-immune patients who have already re-
ceived anti-snakebite serum and shown no reaction may
afely be given a prophylactic dose (l,500 or 3,000 units)
of tetanus antitoxin. They should at the same time be
given their first dose of tetanus formal-toxoid in its
adsorbed form (tetanus PTAP) and be told to attend for
subsequent doses at appropriate intervals. Those fully im-
munized in the past should probably never receive anti-
toxin, certainly not unless more than about 10 years have
passed since the last injection, but receive boosting with
either plain tetanus formol-toxoid (FT) or tetanus PTAP;
the second preparation is preferable because antivenoms
invariably contain some tetanus antitoxin, derived as
they are from horses actively immunized against this
disease.
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.J. The EffecT of EIII';rOllmellwl Temperlllllre
ixty mice received 60 pg. of . lI;vea venom subcutaneuu Iy
and were immediately thereafter placed in groups of 20 at 4 C.
20° and 37°C. The time of injection and the time of death
werc accurately recorded in minutc for each mouse and the
mean log. death time for the 3 groups werc 1·809 ± 0·0301.
1·828 ± 0·0212 and '·608 ± 0·0199: thus there was no
difference between the two 'cool' groups, but the mice kept at
37°C, just below their normal body temperature, fared worse
than the others.
5. The EffecT of Alcohol
A volume of 0·2 ml. of 20 0 0 ethanol (corresponding to 2 G
ethanol/kg. or more than half a bottle of brandy for an
adult man) was given lowly intravenou Iy to mice. and 0·2 ml.
of phy iological saline to other which en'ed as controls.
Tested in a parallel line a say, there was no difference in
the toxicity of . lI;vea venom for the mice of the two groups,
nor was there any difference between the mean log. death-time
for mice of the two groups challenged with a larger dose of
this venom.
A similar experiment with puffadder venom showed a
slight but significant increase in the toxicity for the alcohol-
treated mice, but this effect could not be demonstrated when
the do e of alcohol was halved.
SUMMARV
Three different anti- nakebite sera are available in South
frica, effective against venom of the boom lang, the mamba,
and vipers, cobras and the ringhals.
These sera should not be used lightly or indiscriminately.
The absorption of elapid neurotoxin and the local effect
of viper venom are rapid, wherea the absorption of ami-
venom injected subcutaneously or intramuscularly is slow.
Whenever po sible, the serum should be injected intravenously.
the only truly effective route in systemic poisoning.
The serum dose cannot be tandardized, but it i uggested
that the contents of 2 - 4 ampoules be given when a viper bite
nccessitates intravenous therapy. A suggested scheme for when
and how the tourniquet and serum should be used in the
treatment of nakebite is presented in tabular form.
The general management is briefly discussed. Antihistaminics.
teroids, proteinase inhibitors and chelating agents have no
proven effect clinically on local or systemic snakebite poisoning,
and there is no obviou reason to condemn the use of morphine
if the pain is evere, or to forbid the patient a little alcohol if
he feel it would help him to relax.
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INJURIES TO THE DISTAL TIBIAL EPIPHYSIS*
G. SCHWEITZER, t F.R.A.C.S., Department of Onhopaedics, Baragwanath Hospital and the University of the
Wirwatersrand, Johannesburg
FractL.res and dislocations in the region of the ankle joint
are commonly seen in adults. lnjuries to Ihi region
in children, in particular injuries to the distal tibi:l!
epiphy i, are relativ I uncommon. Some idea of the
frequency of the latter may be obtained from a paper
by Carothers and Cren haw.' These author report that at
the CampbeU Clinic there were 54 cases over a 30-year
period. In one of the fracture clinics at Baragwanath
Hospital, where 60 - 70 patient are seen each week, only 2
cases have been seen over a 12-month period.
Injuries to the distal tibial epiphysis are less common
than injuries to the distal radial epiphysis, to the capitellar
epiphysis of the humerus and to the proximal radial
epiphy is. Injuries to the distal tibial epiphysis are more
common than injuries to the di tal femoral, proximal
humeral and proximal tibial epiphy i and the epiphysis of
the femoral head and phalangeal epiphyse of hand and
foot.
A ATOMY AND PATHOLOGY
The tibia i preformed in cartilage. According to Gray's
Anatomy' the 0 sification centre for the distal end of the
bone appears in the first year of postnatal life. This epiphy-
sis fuses with the shaft at about the age of 15 years in the
female and at the age of 17 in the male. Salter and Harris'
claim that thi centre contributes 45 0 0 of the total
bngitudinal growth of the bone. The epiphysis for the
distal end of the fibula contribute 40"0 of the longitudinal
growth of that bone.
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The epiphysis of a growing bone consists of 4 parts
(Fig. J). These are:
I. The articular cartilage at the end of the bone.
2. The bony epiphyseal centre.
3. The cartilaginou epiphyseal plate.
4. A layer of ossifying cartilage.
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Fig. J. The distal tibial epiphysi and the adjacent epi-
phy eal plate and articular cartilage.
The epiphyseal pJate consists of 4 layers: Cartilage cells
in the resting phase; cartilage cells undergoing rapid pro-
liferation; hypertrophying cartilage cells; and an area where
cartilage cells are being replaced by endochondral ossifica-
tIOn. This layer abuts on the metaphysis.
The cartilage cell are embedded in an acellular matrix
which gives strength and resilience to the epiphyseal plate.
The presence of this malrix enable the epiphyseal plate to
re ist hearing stre es. Calcification of the matrix occurs
in the plane between the hypertrophying cartilage cell and
